Reaction
Tenoplasty reporting signals
As of the last recalculation, Tenoplasty appears in 333 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is UPADACITINIB (PRR 28.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Upadacitinib | 34 | 28.9 | 28.9 |
| Risankizumab-Rzaa | 26 | 21.5 | 21.5 |